ASLAN Pharmaceuticals appoints Robert Hoffman to its Board as Independent Director
– SINGAPORE, Singapore – ASLAN Pharmaceuticals (NASDAQ:ASLN | TPEx:6497), a clinical-stage biopharmaceutical company targeting cancers that are both highly prevalent in Asia and orphan indications in the United States and Europe, announced today the appointment of Robert E.…